I agree that this site is using cookies. You can find further informations here.
X
Wynne, Chris
197  results:
Search for persons X
?
1

Pharmacokinetics, Safety, Tolerability, and Immunogenicity ..:

Schwabe, Christian ; Wynne, Chris ; Dyapa, Dayaker Reddy..
Oncology and Therapy.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

Single‐ and Multiple‐Dose Pharmacokinetics of Gefapixant (M..:

Nussbaum, Jesse C. ; Hussain, Azher ; Butera, Peter...
The Journal of Clinical Pharmacology.  64 (2024)  8 - p. 1023-1029 , 2024
Link: https://doi.org/10.1002/..
 
?
3

Correction to: Safety and Immunogenicity of a Recombinant T..:

Wynne, Chris ; Balgos, Abundio ; Li, Jingxin...
Infectious Diseases and Therapy.  13 (2024)  7 - p. 1723-1724 , 2024
Link: https://doi.org/10.1007/..
 
?
4

42601 Assessment of Bioequivalence Between Candidate Biosim..:

Berti, Fausto ; Wynne, Chris ; Stroissnig, Heimo...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB123 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Safety and Immunogenicity of a Recombinant Two-Component SA..:

Wynne, Chris ; Balgos, Abundio ; Li, Jingxin...
Infectious Diseases and Therapy.  13 (2023)  1 - p. 57-78 , 2023
Link: https://doi.org/10.1007/..
 
?
6

First‐in‐human phase 1 trial evaluating safety, pharmacokin..:

Tang, Fei ; Kunder, Rebecca ; Chu, Tom...
Clinical and Translational Science.  16 (2023)  9 - p. 1653-1666 , 2023
Link: https://doi.org/10.1111/..
 
?
7

Phase I and scintigraphy studies to evaluate safety, tolera..:

Zhu, Rui ; Chen, Hubert ; Galanter, Joshua...
Clinical and Translational Science.  15 (2022)  5 - p. 1225-1237 , 2022
Link: https://doi.org/10.1111/..
 
?
8

Pharmacokinetics and pharmacodynamics of a proposed tociliz..:

Schwabe, Christian ; Illes, Andras ; Ullmann, Martin...
Expert Review of Clinical Immunology.  18 (2022)  5 - p. 533-543 , 2022
Link: https://doi.org/10.1080/..
 
?
9

A randomized phase I study comparing the pharmacokinetics o..:

Demarchi, Martin ; Coliat, Pierre ; Barthelemy, Philippe...
PLOS ONE.  16 (2021)  9 - p. e0248222 , 2021
Link: https://doi.org/10.1371/..
 
?
10

A Phase 1 Study to Evaluate the Safety, Tolerability, and P..:

Owen, Ryan ; Galanter, Joshua ; Zhu, Rui...
Journal of Allergy and Clinical Immunology.  145 (2020)  2 - p. AB17 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Bioavailability of Orally Administered Active Lipid Compoun..:

Miller, Matthew R. ; Kruger, Marlena C. ; Wynne, Chris...
Marine Drugs.  18 (2020)  11 - p. 524 , 2020
Link: https://doi.org/10.3390/..
 
?
12

Immunogenicity and safety of a proposed pegfilgrastim biosi..:

Wynne, Chris ; Schwabe, Christian ; Vincent, Emmanuelle...
Pharmacology Research & Perspectives.  8 (2020)  2 - p. , 2020
Link: https://doi.org/10.1002/..
 
?
13

A Global Phase I Clinical Study Comparing the Safety and Ph..:

Wu, Xiaoyun ; Wynne, Chris ; Xu, Chenchao...
BioDrugs.  33 (2019)  3 - p. 335-342 , 2019
Link: https://doi.org/10.1007/..
 
?
14

A comparative pharmacokinetic study of DRL_BZ, a candidate ..:

Wynne, Chris ; Schwabe, Christian ; Batra, Sonica Sachdeva..
British Journal of Clinical Pharmacology.  84 (2018)  10 - p. 2352-2364 , 2018
Link: https://doi.org/10.1111/..
 
?
15

Development of a Subcutaneous Fixed‐Dose Combination of Per..:

Kirschbrown, Whitney P. ; Wynne, Chris ; Kågedal, Matts...
The Journal of Clinical Pharmacology.  59 (2018)  5 - p. 702-716 , 2018
Link: https://doi.org/10.1002/..
 
1-15